Jonathan Brennan Badal
About Jonathan Brennan Badal
Jonathan Brennan Badal serves as the CEO of Opentrons Labworks Inc. in Brooklyn since 2016, bringing extensive experience from previous roles including Board Member at Genspace and VP of Strategy at comiXology.
Work at Opentrons
Jonathan Brennan Badal has served as the CEO of Opentrons Labworks Inc. since 2016. Under his leadership, the company has focused on developing accessible and affordable automation solutions for laboratories. His tenure has been marked by efforts to enhance laboratory efficiency and streamline workflows through innovative technology. Opentrons is based in Brooklyn, where Badal has contributed to the company's growth and presence in the biotech sector.
Previous Experience at Genspace
Before joining Opentrons, Jonathan Brennan Badal was a Board Member at Genspace from 2015 to 2022. Genspace is a community biolab located in New York that provides resources and education in biotechnology. During his time on the board, Badal contributed to the organization's mission of making biotechnology accessible to the public and fostering innovation in the field.
Career at comiXology
Jonathan Brennan Badal worked as the VP of Strategy at comiXology, an Amazon company, from 2011 to 2016. In this role, he was responsible for strategic planning and initiatives that supported the company's growth in the digital comics market. His leadership helped position comiXology as a leading platform for comic book readers and creators.
Education at Columbia University
Jonathan Brennan Badal has been studying at Columbia College, Columbia University since 2009. His education at this prestigious institution has provided him with a strong foundation in various disciplines, contributing to his professional development and leadership capabilities in the biotechnology and technology sectors.
Early Career at Rose Tech Ventures
Jonathan Brennan Badal began his career as an Analyst at Rose Tech Ventures, where he worked from 2009 to 2011. In this role, he was involved in evaluating investment opportunities and supporting the firm's strategic initiatives. This early experience in venture capital laid the groundwork for his future roles in technology and biotechnology.